Research and Markets has announced the addition of the "The Future of the In-Vitro Diagnostics Market to 2016 – Increasing Diagnostic Procedures Drive Demand" report to their offering.
“The Future of the In-Vitro Diagnostics Market to 2016 – Increasing Diagnostic Procedures Drive Demand”
The report provides key data, information and analysis on the global in-vitro diagnostics market, and on market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories: Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology.
The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Global In-Vitro Diagnostics (IVD) market set to boom in the next seven years driven by ageing population
The global IVD market is forecast to grow to $49,843.5m by 2016 at the rate of 4.3% over the next seven years. Clinical chemistry and the immuno chemistry markets will be the largest IVD categories, accounting for more than 60% of the total revenues. These markets are expected to grow at 4.5% and 4.7% CAGR (Compounded Annual Growth Rate) between 2009 and 2016 to reach $16,425.3m and $14,136.1m respectively.
The genetic testing market will be the fastest growing market at a CAGR of 6.7% during 20092016 to become an over the billion dollar market. The global IVD market will be driven by new technological advancements, a shift towards more complex immunochemistry tests to Point of Care (POC), and the adoption of cost cutting measures such as increased automation and self testing. Major technological advancements such as next generation DNA sequencing, molecular imaging, and microfluidics-based diagnostic devices are expected to drive growth in categories such as immunochemistry and genetic testing.
Need to control costs at laboratories to drive adoption of new processes and instruments
Cost reduction has become the primary theme of healthcare reforms globally. To survive and succeed in these challenging conditions, it is imperative for laboratories to look for ways to adapt and implement new strategies to help them save on costs. In todays competitive environment, revenues per test are continually falling, requiring testing centers to increase their productivity for survival. The paradigm shift towards improved quality, error free services, and the need to ensure patient satisfaction to retain their allegiance has prompted laboratories to adopt novel technologies such as automation, and point of care in order to reduce their expenses. The acceptance of new technologies is expected to drastically improve among those who are currently reluctant to invest to achieve long term cost reduction goals.
Key topics covered include:
- 1 TOC
- 2 Introduction and Overview
- 3 Global IVD Market: Market Characterization
- 4 Global IVD Market: Market Category Analysis and Forecasts
- 5 Global IVD Market: Country Analysis and Forecasts
- 6 Global IVD Market: Strategic Competitive Assessment
- 7 Global IVD Market: Product Pipeline Analysis
- 8 Global IVD Market: Consolidation Landscape
- 9 Appendix
- List of Tables
- List of Figures
Companies mentioned include:
- F. Hoffmann-La Roche Ltd
- Siemens Medical Solutions USA Inc
- Abbott Laboratories
- Beckman Coulter Inc
- bioMerieux Sa
- Ortho-Clinical Diagnostics
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Inverness Medical Innovations Inc
Source: Research and Markets